A House Democrat and Republican on Wednesday highlighted their push to expand access to clinical trials, saying artificial ...

Artificial intelligence (AI) can rapidly screen patients for clinical trial enrollment, according to a new study published in JAMA and led by Mass General Brigham researchers. Their novel AI-assisted ...

A new study in the journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates.

HealthDay News — Compared with manual screening, an artificial intelligence (AI)-assisted patient screening tool can improve the rate of eligibility determination and enrollment for randomized ...

Through OpenAI's Impact Hours program, which supports high-impact projects designed to benefit large population areas, Massive Bio is enabling real-time trial parameterization and free pre-screening ...

Resolving disparities in access to cancer care in LMIC-positive learning using a 10-year-old model. Performance of various AG-LLMs for clinical trial matching. 1 200 of 240 profiles used for ...

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success ...

Mass General Brigham has announced the development of an AI company and screening tool that has sped up the process for determining a patient’s eligibility and enrollment for clinical trials.

Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly ...

Clinical trials are the irreplaceable engine of drug development and a bedrock of modern medicine, yet patient enrollment ...